Dimension | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Dimension/Activity

Dimension Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Exit

Portfolio company Odyssey Therapeutics began trading on Nasdaq under ODTX after pricing an upsized IPO.

Odyssey Therapeutics

Odyssey Therapeutics Dimension

nasdaq.comMAY 8, 2026

investors.odysseytx.com

MAY 8, 2026

News

STAT reported Dimension had started raising its third fund, targeting around $700M for AI-and-science companies.

Fund III fundraising target

statnews.comMAR 17, 2026

MAR 17, 2026

New Fund

Raising Fund III targeting approximately $700 million to invest in AI + science companies.

Fund III

statnews.comMAR 17, 2026

MAR 17, 2026

4 investments· SEP 2025 – FEB 2026Show all

Investment

Led Tamarind Bio’s $12M Series A as part of a $13.6M fundraise for AI drug discovery infrastructure.

Tamarind Bio

Tamarind Bio Dimension

tamarind.bioFEB 26, 2026

dimensioncap.com

FEB 26, 2026

Investment

Made a new investment in BioRender valuing the scientific visualization platform at $900M.

BioRender

BioRender Dimension

biorender.comDEC 18, 2025

DEC 18, 2025

Investment

Participated in Chai Discovery’s $130M Series B at a $1.3B valuation.

Chai Discovery

Chai Discovery Dimension

techcrunch.comDEC 15, 2025

DEC 15, 2025

Investment

Led Odyssey Therapeutics’ oversubscribed $213M Series D for immunology drug development.

Odyssey Therapeutics

Odyssey Therapeutics Dimension

dimensioncap.comSEP 10, 2025

SEP 10, 2025